Adamantane 281-23-2
  • Adamantane 281-23-2 Adamantane 281-23-2

Adamantane 281-23-2

Barka da zuwa siyan Adamantane 281-23-2 daga gare mu. Amantadine, wanda aka fi sani da amantadine ko tricyclodecylamine, an fara amfani da shi azaman maganin rigakafi kuma daga baya aka gano yana da tasirin cutar Parkinson. 1. Cutar Anti-parkinson: Bayan amantadine ya shiga cikin kwakwalwa, Chemicalbook na iya inganta sakin masu watsa kwayar cutar dopamine daga kwayoyin cutar dopaminergic kuma ya hana sake dawowa na dopamine. Haka kuma, Littafin sinadarai na iya tada masu karɓar dopamine kai tsaye, kuma ingancin sa bai yi kyau ba

Aika tambaya

Bayanin Samfura

Believe Chemical shine Adamantane 281-23-2 masana'antun da masu kaya a China wadanda zasu iya yin jumulla Adamantane 281-23-2. Shandong Amince


Adamantane 281-23-2 Bayanin Sinadari

Sunan samfur

Adamantane

Formula

C10H16

Nauyin Kwayoyin Halitta

136.23

CAS NO.

281-23-2

Yawan

500KG


Abubuwa

Ƙayyadaddun bayanai

Sakamako

Bayyanar

Farin lu'u-lu'u

Ya dace

Assay

â¥99%

Ya dace

Wurin narkewa

209-212 ° C (subl.) (lit.)

Ya dace

Yawan yawa

1.07 g/cm 3

Ya dace

KAMMALAWA

Sakamakon ya dace da ma'auni


Adamantane 281-23-2 Abubuwan Sinadarai

Synonym: TRICYCLO[3.3.1.1] DECANE; TRICYCLO[3.3.1.13,7]DECANE; TRICYCLODECANE; ;decahydro-3,5,1,7-[1,2,3,4]butatetraylnaphthalene;Tricyclo(3,3,1,1,3,7) -decane


CAS:

Tsarin kwayoyin halitta:

Nauyin kwayoyin halitta:

Saukewa: 206-001-4

Wurin tafasa:

Yawan yawa:

Yanayin ajiya:

Indexididdigar raɗaɗi:

Rayuwar rayuwa: 2 shekaru


Adamantane 281-23-2 Chemical

Adamantane CAS

Adamantane CAS



Zafafan Tags: Adamantane 281-23-2, Masu masana'antu, Masu ba da kayayyaki, Dillalai, Masana'antu, A cikin Hannun jari, An yi a China, China, Mai rahusa, Rangwame, Inganci, API, Bincike da haɓakawa

Samfurin Tag

Rukunin da ke da alaƙa

Aika tambaya

Da fatan za a ji daɗin ba da tambayar ku a cikin fom ɗin da ke ƙasa. Za mu ba ku amsa a cikin sa'o'i 24.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept